| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 264.59B | 182.94B | 278.09B | 260.82B | 192.91B | 202.99B |
| Gross Profit | 26.45B | 6.45B | 25.21B | 27.49B | 23.45B | 20.04B |
| EBITDA | 8.13B | -16.01B | 4.85B | 15.00B | 6.87B | 4.64B |
| Net Income | 1.51B | -14.94B | 2.02B | 9.82B | 1.65B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 252.57B | 261.14B | 286.60B | 286.00B | 256.31B | 240.85B |
| Cash, Cash Equivalents and Short-Term Investments | 79.55B | 105.25B | 90.32B | 119.86B | 108.52B | 92.15B |
| Total Debt | 51.14B | 60.82B | 51.91B | 36.28B | 36.59B | 36.68B |
| Total Liabilities | 195.01B | 217.43B | 226.35B | 221.84B | 207.20B | 196.29B |
| Stockholders Equity | 57.35B | 43.51B | 60.01B | 63.94B | 48.92B | 44.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.74B | -27.18B | 4.63B | 14.64B | -7.56B |
| Operating Cash Flow | 0.00 | 9.30B | -23.09B | 6.00B | 15.59B | -6.79B |
| Investing Cash Flow | 0.00 | 159.00M | -19.77B | 7.34B | -9.47B | -7.85B |
| Financing Cash Flow | 0.00 | 6.26B | 674.00M | -1.06B | -1.57B | 7.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥259.31B | 9.89 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥1.32T | 17.13 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥643.42B | 11.33 | ― | 2.15% | 0.46% | 38.67% | |
71 Outperform | ¥680.09B | 13.13 | -0.24% | 2.10% | -13.15% | ― | |
69 Neutral | ¥210.02B | 2.74 | 164.12% | ― | 8.09% | 213.68% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥126.98B | -6.97 | -33.76% | 0.96% | -34.22% | -810.14% |